C Diff, The Miserable And Deadly Infection You’ve Likely Never Heard About
WHAT IS C. DIFF? And Why You NEED to Avoid This Silent Killer
You've just been diagnosed with C. diff—and your first thought is, "WHAT THE HELL IS THIS?!" Let's break it down:
If you're "lucky": Debilitating abdominal cramps, explosive diarrhea, and weeks of misery.
If you're not: Relentless relapses, a 6% mortality rate, or even sudden death in severe cases. For those over 65 or hospitalized with chronic conditions, the 30-day death risk skyrockets.
Bottom line: You've probably never heard of C. diff... but you definitely don't want it.
The Harsh Reality of C. difficile
Cases annually in the US
Deaths each year
Experience relapses
Hospital-acquired infection
C. diff spores can survive for months on surfaces and are resistant to most disinfectants. Antibiotics that treat other infections actually make you MORE vulnerable to C. diff by destroying your protective gut flora.
CDiffcontrol
Introducing The Triple Win in C. diff Protection
Simple. Safe. Sustainable.
Patients stay well, the healthcare system saves more than it spends, and providers earn a fair return..
MEET CDIFFCONTROL: YOUR GUT'S NEW BODYGUARD
CDiffControl: Stop C. Diff Before it Starts.
When you get C. Difficile infection your body makes antibodies to try and fight it but this is only successful in about 20% of cases. CDiffControl gives you those protective antibodies proactively. You take them orally, so they go right to your gut. There, they find the C. Diff bacteria and neutralize them, preventing an infection from ever taking hold. It's like an insurance policy for your gut health.
Safety First
If you can eat eggs, you can take CDiffControl (It's made from pasteurized, spray-dried egg antibodies—no scary side effects.)
"I had taken antibiotics to treat my diverticulitis. A few weeks later I was having diarrhea and thought it was another bout. I gave a stool sample and was diagnosed with C. Diff, which I had never heard of. They gave me another antibiotic to treat this, which set off 8 months of 7 recurrent infections. I took Immunimed’s oral antibody treatment and finally got better. It was simple to take and no side effects. If I’d known then what I know now about C. Diff and their preventive treatment was available, I would have taken it for sure."
"I was given the antibiotic Amoxicillin/clavulanic Acid after laser prostate surgery in 2022. The pharmacist did note that C. Difficile could be a rare complication. Within days of completing the antibiotics, I developed severe cramping & diarrhea. I was now given another set of antibiotics to treat C. Diff. Unfortunately, several weeks later I again was suffering from C. Diff. Fortunately, I was put in contact with John Hare. He immediately had me enrolled in their phase 2 clinical trial treatment of Egg-derived polyclonal antibodies. In less than a week I was symptom free and the C. Diff never returned. Had I been given this as a preventive treatment together with the initial antibiotics, I probably would have been spared the infection altogether, along with a lot of pain & discomfort. A preventive medicine for C. Difficile infection could be a life-saver."
When Should You Take CDiffControl?
During/after antibiotics or PPIs
These treatments nuke your gut's "good bacteria," leaving you exposed to C. diff infection.
Before or during hospital stays
C. diff is now the #1 hospital-acquired infection in the U.S. Hospitals are crawling with the bacteria, and 50% of patients are on antibiotics.
After previous C. diff infection
20% of patients experience relapses. CDiffControl helps prevent recurring infections.
Simple Protection Protocol
How it works: Mix 10g (1 scoop) of powder with milk or milk substitute daily for 36 days—the time it takes your gut to recover. One daily serving = one antibody-packed egg. Simple.
"36 days sounds long!" Sure, but it's better than months of relapses... or a funeral.
Don't gamble with C. diff. Protect your gut, save your life.
CDiffControl is an investigational product currently under development for the prevention of Clostridioides difficile infection (CDI). It is not yet approved by regulatory authorities and not available for purchase or medical use. Website content and product visuals are illustrative only, showing how CDiffControl may appear once authorized for use. Clinical studies of our related therapeutic antibody (IM-01) have demonstrated 94% efficacy, and further studies are planned to evaluate CDiffControl for prevention.
NOTE TO PARTNERS:
CDiffControl represents our preventive formulation of the same antibodies currently in Phase 2 trials to treat CDI . We are actively pursuing funding to advance this preventive indication.
Innovation Announcement
Groundbreaking Research in C. difficile Infection Prevention
Use of Egg-Derived Polyclonal Anti-Clostridioides difficile Antibodies for the Prevention of C. difficile Infection
We are proud to announce Patent Pending status of our novel approach to preventing Clostridioides difficile infection using egg-derived polyclonal antibodies. This innovative technology represents a significant advancement in the fight against C. difficile, a major cause of healthcare-associated infections worldwide.
Our research team has developed a proprietary method for producing highly effective antibodies that target various components causing C. difficile infection, offering a promising preventive strategy for at-risk populations.
Innovative Approach
Utilizes egg-derived polyclonal antibodies specifically targeting C. difficile components.
Preventive Strategy
Designed to prevent C. difficile infection in susceptible individuals before it occurs.
Natural Origin
Leverages natural immune mechanisms for a potentially safer therapeutic option.
Patent Status: Application Submitted - Patent Pending
Hospital acquired
Personal Contact
Antibiotic use
Contaminated Object
C Diff Control
More Information About C Diff Infection
C Difficile Infection is now the most common hospital acquired illness in the U. S., with an annual cost of more than $5B to its Healthcare system. It is also classified as an “urgent threat” (the highest category) by the Center for Disease Control (CDC) for Antimicrobial Resistance (AMR).
- Approximately 50% of CDI cases are now found to originate outside of hospitals, raising concern for the uninformed public with limited knowledge of the disease.
- C Diff is a gram positive spore forming highly contagious bacteria that causes profuse diarrhea, nausea, cramping, colitis and death in some cases. It infects 500,000 and kills 30,000 North Americans every year. It also has a high probability of reinfecting the same patient multiple times over many months.
- Almost all cases of C Diff infection occur while you’re taking antibiotics or not long thereafter. This happens because these antibiotics knock out your gut microflora making you susceptible to CDI.
- We are presently in phase 2 clinical trials of our orally administered antibodies to CURE CDI, with a 94% cure rate after 130 patients. Though not yet approved, from results to date this is the safest and most reliable cure for CDI.
- We are confident a combination of these same antibodies can be used to avoid getting CDI.
